Reviewed,
UniProtKB/Swiss-Prot P28068 (2DMB_HUMAN)
Last modified
September 23, 2008.
Version 84.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: HLA class II histocompatibility antigen, DM beta chain Alternative name(s): MHC class II antigen DMB | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 263 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Plays a critical role in catalyzing the release of class II HLA-associated invariant chain-derived peptides (CLIP) from newly synthesized class II HLA molecules and freeing the peptide binding site for acquisition of antigenic peptides. |
| Subunit structure | Heterodimer of an alpha chain (DMA) and a beta chain (DMB). |
| Subcellular location | Late endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note= Localizes to late endocytic compartment. Associates with lysosome membranes. |
| Domain | The YXXZ (Tyr-Xaa-Xaa-Zaa, where Zaa is a hydrophobic residue) motif mediates the targeting to the lysosomal compartments. |
| Polymorphism | The following alleles of DMB are known: DMB*0101, DMB*0102, DMB*0103, DMB*0104 (DMB3.4), DMB*0105 and DMB*0106. The sequence shown is that of DMB*0101. |
| Sequence similarities | Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. |
Ontologies
Keywords | |
|---|---|
| Biological process | Immune response |
| Cellular component | Endosome Lysosome MHC II Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Signal Transmembrane |
| PTM | Glycoprotein |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Cellular component | plasma membrane Inferred from Experiment. Source: Reactome |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 18 | 18 | Potential | |||||||||||||||||||||||||||||||||||||||
| Chain | 19 – 263 | 245 | HLA class II histocompatibility antigen, DM beta chain | |||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 19 – 218 | 200 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||
| Transmembrane | 219 – 239 | 21 | Potential | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 240 – 263 | 24 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||
| Domain | 114 – 208 | 95 | Ig-like C1-type | |||||||||||||||||||||||||||||||||||||||
| Region | 19 – 112 | 94 | Beta-1 | |||||||||||||||||||||||||||||||||||||||
| Region | 113 – 207 | 95 | Beta-2 | |||||||||||||||||||||||||||||||||||||||
| Region | 208 – 218 | 11 | Connecting peptide Potential | |||||||||||||||||||||||||||||||||||||||
| Motif | 248 – 251 | 4 | YXXZ motif | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 110 | 1 | N-linked (GlcNAc...) | |||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 45 | 1 | S → F in allele DMB*0106. | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 162 | 1 | A → E in allele DMB*0102 and allele DMB*0106. | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 162 | 1 | A → V in allele DMB*0104 and allele DMB*0105. | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 197 | 1 | I → T in allele DMB*0103, allele DMB*0104 and allele DMB*0106. dbSNP rs1042337. | |||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 248 | 1 | Y → A: Abolishes targeting to endosomes and results in relocalization to the cell membrane | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 251 | 1 | L → A: Abolishes targeting to endosomes and results in relocalization to the cell membrane | |||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 22 – 32 | 11 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 37 – 46 | 10 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 49 – 55 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 56 – 59 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 60 – 63 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 71 – 81 | 11 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 84 – 89 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 93 – 101 | 9 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 102 – 104 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 105 – 109 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 116 – 121 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 126 – 128 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 130 – 143 | 14 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 146 – 151 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 172 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 174 – 182 | 9 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 190 – 195 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 199 – 201 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 203 – 207 | 5 | ||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A new human HLA class II-related locus, DM." Kelly A.P., Monaco J.J., Cho S., Trowsdale J. Nature 353:571-573(1991) [PubMed: 1922365] [Abstract] Cited for: NUCLEOTIDE SEQUENCE (ALLELE DMB*0101). |
| [2] | "Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex." Radley E., Alderton R.P., Kelly A., Trowsdale J., Beck S. J. Biol. Chem. 269:18834-18838(1994) [PubMed: 8034636] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DMB*0101). |
| [3] | "Evolutionary dynamics of non-coding sequences within the class II region of the human MHC." Beck S., Abdulla S., Alderton R.P., Glynne R.J., Gut I.G., Hosking L.K., Jackson A., Kelly A., Newell W.R., Sanseau P., Radley E., Thorpe K.L., Trowsdale J. J. Mol. Biol. 255:1-13(1996) [PubMed: 8568858] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DMB*0101). |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DMB*0101). Tissue: Lymph. |
| [5] | "Limited polymorphism in HLA-DM does not involve the peptide binding groove." Sanderson F., Powis S.H., Kelly A.P., Trowsdale J. Immunogenetics 39:56-58(1994) [PubMed: 8225438] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 114-207 (ALLELES DMB*0102 AND DMB*0103). |
| [6] | "Characterization of HLA-DMB polymorphism." Carrington M., Yeager M., Mann D. Immunogenetics 38:446-449(1993) [PubMed: 8406617] [Abstract] Cited for: NUCLEOTIDE SEQUENCE OF 121-200 (ALLELE DMB*0104). |
| [7] | "Three HLA-DMB variants in Korean patients with autoimmune diseases." Kim T.-G., Carrington M., Choi H.B., Kim H.Y., Han H. Hum. Immunol. 46:58-60(1996) [PubMed: 9157091] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 113-207 (ALLELE DMB*0105). Tissue: Blood. |
| [8] | "The nucleotide sequence of a new DMB allele, DMB*0106." McTernan C.L., Mijovic C.H., Cockram C.S., Barnett A.H. Tissue Antigens 55:470-472(2000) [PubMed: 10885572] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 19-112 AND 152-207 (ALLELE DMB*0106). |
| [9] | "Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM." Weber D.A., Evavold B.D., Jensen P.E. Science 274:618-620(1996) [PubMed: 8849454] [Abstract] Cited for: FUNCTION. |
| [10] | "Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB." Copier J., Kleijmeer M.J., Ponnambalam S., Oorschot V., Potter P., Trowsdale J., Kelly A. J. Immunol. 157:1017-1027(1996) [PubMed: 8757605] [Abstract] Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF TYR-248 AND LEU-251. |
| [11] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, MASS SPECTROMETRY. Tissue: Plasma. |
| [12] | "The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation." Mosyak L., Zaller D.M., Wiley D.C. Immunity 9:377-383(1998) [PubMed: 9768757] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 19-218. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z23139 mRNA. Translation: CAA80670.1. U15085 mRNA. Translation: AAB60387.1. X76776 Genomic DNA. Translation: CAA54171.1. X87344 Genomic DNA. Translation: CAA60782.1. BC027175 mRNA. Translation: AAH27175.1. Z24750 Genomic DNA. No translation available. Z24751 Genomic DNA. No translation available. U00700 Genomic DNA. Translation: AAA03296.1. U16762 Genomic DNA. Translation: AAC50514.1. AF134890 Genomic DNA. Translation: AAD30279.1. AF072680 Genomic DNA. Translation: AAC26112.1. | |||||||||||||||||||
| PIR | I37533. | ||||||||||||||||||
| RefSeq | NP_002109.1. | ||||||||||||||||||
| UniGene | Hs.654428 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP:6185N. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000206294. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 3109. | ||||||||||||||||||
| KEGG | hsa:3109. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| H-InvDB | HIX0005762. HIX0057755. HIX0057992. | ||||||||||||||||||
| HGNC | HGNC:4935. HLA-DMB. | ||||||||||||||||||
| HPA | HPA007113. | ||||||||||||||||||
| MIM | 142856. gene. | ||||||||||||||||||
| PharmGKB | PA35059. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOGENOM | P28068. | ||||||||||||||||||
| HOVERGEN | P28068. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| CleanEx | HS_HLA-DMB. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR013151. Ig. IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR003006. Ig/MHC_CS. IPR003597. Ig_C1-set. IPR014745. MHC_II_a/b_N. IPR000353. MHC_II_b_N. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:2.60.40.10. Ig-like_fold. 1 hit. G3DSA:3.10.320.10. MHC_II_alpha_N. 1 hit. | ||||||||||||||||||
| Pfam | PF00047. ig. 1 hit. PF00969. MHC_II_beta. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00407. IGc1. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. PS00290. IG_MHC. 1 hit. [Graphical view] | ||||||||||||||||||
| ProDom | P28068. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||
| BLOCKS | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | 2DMB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P28068 Secondary accession number(s): O77936 Q9XRX2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


